Cargando…
Reducing catheter-associated complications using 4% sodium citrate versus sodium heparin as a catheter lock solution
OBJECTIVE: Use of a catheter lock solution plays a decisive role in vascular access. The effects of different concentrations of heparin and different types of catheter lock solutions are controversial. Therefore, this study aimed to compare the efficacy and safety of sodium citrate and sodium hepari...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753535/ https://www.ncbi.nlm.nih.gov/pubmed/31304818 http://dx.doi.org/10.1177/0300060519859143 |
_version_ | 1783452907672174592 |
---|---|
author | Huang, He-ming Jiang, Xin Meng, Ling-bing Di, Chen-yi Guo, Peng Qiu, Yong Dai, Ya-lun Lv, Xian-qiang Shi, Chang-jin |
author_facet | Huang, He-ming Jiang, Xin Meng, Ling-bing Di, Chen-yi Guo, Peng Qiu, Yong Dai, Ya-lun Lv, Xian-qiang Shi, Chang-jin |
author_sort | Huang, He-ming |
collection | PubMed |
description | OBJECTIVE: Use of a catheter lock solution plays a decisive role in vascular access. The effects of different concentrations of heparin and different types of catheter lock solutions are controversial. Therefore, this study aimed to compare the efficacy and safety of sodium citrate and sodium heparin catheter lock solutions. METHODS: A total of 120 patients were divided into four groups (30 patients per group) according to the use of catheter lock solution as follows: 6250 U/mL sodium heparin, 5000 U/mL sodium heparin, 2500 U/mL sodium heparin, and 4% sodium citrate. Coagulation function and the incidence of catheter occlusion, hemorrhage, and catheter-related infections were recorded. RESULTS: The different catheter lock solutions were significantly related to conduit blockage, hemorrhage, infection, and leakage levels. In the 4% sodium citrate group, the odds ratio was 0.688 for conduit blockage (95% confidence interval [CI], 0.206–2.297), 0.286 for hemorrhage (95% CI, 0.091–0.899), 0.266 for infection (95% CI, 0.073–0.964), and 0.416 for leakage (95% CI, 0.141–1.225) compared with the 6250 U/mL sodium heparin. CONCLUSIONS: The solution 4% sodium citrate can effectively reduce the risk of catheter obstruction, bleeding, infection, and leakage better than sodium heparin in patients with long-term intravenous indwelling catheters. |
format | Online Article Text |
id | pubmed-6753535 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-67535352019-09-25 Reducing catheter-associated complications using 4% sodium citrate versus sodium heparin as a catheter lock solution Huang, He-ming Jiang, Xin Meng, Ling-bing Di, Chen-yi Guo, Peng Qiu, Yong Dai, Ya-lun Lv, Xian-qiang Shi, Chang-jin J Int Med Res Clinical Research Reports OBJECTIVE: Use of a catheter lock solution plays a decisive role in vascular access. The effects of different concentrations of heparin and different types of catheter lock solutions are controversial. Therefore, this study aimed to compare the efficacy and safety of sodium citrate and sodium heparin catheter lock solutions. METHODS: A total of 120 patients were divided into four groups (30 patients per group) according to the use of catheter lock solution as follows: 6250 U/mL sodium heparin, 5000 U/mL sodium heparin, 2500 U/mL sodium heparin, and 4% sodium citrate. Coagulation function and the incidence of catheter occlusion, hemorrhage, and catheter-related infections were recorded. RESULTS: The different catheter lock solutions were significantly related to conduit blockage, hemorrhage, infection, and leakage levels. In the 4% sodium citrate group, the odds ratio was 0.688 for conduit blockage (95% confidence interval [CI], 0.206–2.297), 0.286 for hemorrhage (95% CI, 0.091–0.899), 0.266 for infection (95% CI, 0.073–0.964), and 0.416 for leakage (95% CI, 0.141–1.225) compared with the 6250 U/mL sodium heparin. CONCLUSIONS: The solution 4% sodium citrate can effectively reduce the risk of catheter obstruction, bleeding, infection, and leakage better than sodium heparin in patients with long-term intravenous indwelling catheters. SAGE Publications 2019-07-15 2019-09 /pmc/articles/PMC6753535/ /pubmed/31304818 http://dx.doi.org/10.1177/0300060519859143 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Clinical Research Reports Huang, He-ming Jiang, Xin Meng, Ling-bing Di, Chen-yi Guo, Peng Qiu, Yong Dai, Ya-lun Lv, Xian-qiang Shi, Chang-jin Reducing catheter-associated complications using 4% sodium citrate versus sodium heparin as a catheter lock solution |
title | Reducing catheter-associated complications using 4% sodium citrate
versus sodium heparin as a catheter lock solution |
title_full | Reducing catheter-associated complications using 4% sodium citrate
versus sodium heparin as a catheter lock solution |
title_fullStr | Reducing catheter-associated complications using 4% sodium citrate
versus sodium heparin as a catheter lock solution |
title_full_unstemmed | Reducing catheter-associated complications using 4% sodium citrate
versus sodium heparin as a catheter lock solution |
title_short | Reducing catheter-associated complications using 4% sodium citrate
versus sodium heparin as a catheter lock solution |
title_sort | reducing catheter-associated complications using 4% sodium citrate
versus sodium heparin as a catheter lock solution |
topic | Clinical Research Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753535/ https://www.ncbi.nlm.nih.gov/pubmed/31304818 http://dx.doi.org/10.1177/0300060519859143 |
work_keys_str_mv | AT huangheming reducingcatheterassociatedcomplicationsusing4sodiumcitrateversussodiumheparinasacatheterlocksolution AT jiangxin reducingcatheterassociatedcomplicationsusing4sodiumcitrateversussodiumheparinasacatheterlocksolution AT menglingbing reducingcatheterassociatedcomplicationsusing4sodiumcitrateversussodiumheparinasacatheterlocksolution AT dichenyi reducingcatheterassociatedcomplicationsusing4sodiumcitrateversussodiumheparinasacatheterlocksolution AT guopeng reducingcatheterassociatedcomplicationsusing4sodiumcitrateversussodiumheparinasacatheterlocksolution AT qiuyong reducingcatheterassociatedcomplicationsusing4sodiumcitrateversussodiumheparinasacatheterlocksolution AT daiyalun reducingcatheterassociatedcomplicationsusing4sodiumcitrateversussodiumheparinasacatheterlocksolution AT lvxianqiang reducingcatheterassociatedcomplicationsusing4sodiumcitrateversussodiumheparinasacatheterlocksolution AT shichangjin reducingcatheterassociatedcomplicationsusing4sodiumcitrateversussodiumheparinasacatheterlocksolution |